Protein features in PepsiCo’s portfolio push in both snacks and beverages to embrace consumer interest in health.

CEO Ramon Laguarta said the Doritos maker hasn’t seen a “direct impact” from GLP-1 medications despite a higher level of awareness among consumers toward health and wellness.

PepsiCo ended the fiscal year 2024 with further declines in its snack business with five back-to-back quarters of volume ...

PepsiCo (PEP) , which owns popular food and drink brands such as Pepsi, Lay’s, Gatorade, Tostitos, and many others, recently ...

Analyzing PepsiCo, Inc.'s stock drop, financial health, and growth strategies, highlighting a buying opportunity for ...

Highlighting that its international business continues to remain profitable, PepsiCo, a global food and beverages major has ...

New Delhi: Global food & beverages major PepsiCo has reported double-digit organic revenue growth in the Indian market in 2024. The company has gained a share in markets, including India, in savoury ...

PepsiCo stock is lower Tuesday after the soft drink maker's top-line miss offsets an earnings beat and dividend hike. Here's ...

Rising consumer demand for fewer empty calories is pushing the snack and beverage giant to offer options with less sodium, ...

PepsiCo’s revenue fell slightly in the fourth quarter as North American consumers continued to pull back on its Frito-Lay ...

PepsiCo reported double-digit organic growth in its convenience foods and beverage categories in India on Tuesday, despite ...

WALL Street stocks rose on Tuesday, shrugging off early weakness while embracing President Trump’s moves to delay tariffs on ...